Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

184.89
0.0000
Post-market: 182.00-2.8900-1.56%19:30 EDT
Volume:440.10K
Turnover:81.72M
Market Cap:10.91B
PE:-56.97
High:187.60
Open:185.00
Low:183.68
Close:184.89
52wk High:191.62
52wk Low:73.16
Shares:58.98M
Float Shares:56.44M
Volume Ratio:0.65
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2456
EPS(LYR):-3.2819
ROE:-25.98%
ROA:-5.18%
PB:15.98
PE(LYR):-56.34

Loading ...

Analyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth

TIPRANKS
·
Jun 03

Glaukos pullback due to concerns about iDose LCD, says William Blair

TIPRANKS
·
May 27

Goldman Sachs Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
May 26

Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook

TIPRANKS
·
May 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)

TIPRANKS
·
May 22

Glaukos: Buy Rating Reiterated as Favorable iDose LCD Eases Reimbursement Overhang and Sets Stage for Epioxa-Driven Growth

TIPRANKS
·
May 22

Glaukos Corp : Btig Raises Target Price to $162 From $141

THOMSON REUTERS
·
May 21

Glaukos Is Maintained at Buy by BTIG

Dow Jones
·
May 21

Glaukos director Gilbert H. Kliman disposes 5,000 common shares for $703,800

Reuters
·
May 19

Glaukos director Gilbert H. Kliman disposes of 5,000 common shares for $675,000

Reuters
·
May 14

Medical Device Stocks Are Ready to Bounce. Two Names to Buy Now. -- Barrons.com

Dow Jones
·
May 14

Glaukos management to speak at Stifel Virtual Ophthalmology Forum

Reuters
·
May 12

Glaukos CFO Alex Thurman disposes 10,000 common shares worth $1.4 million

Reuters
·
May 05

Glaukos President, COO Joseph Gilliam sells 19,573 shares worth $2.81 million

Reuters
·
May 05

Glaukos director Leana Wen sells 1,700 shares for $243,695‬

Reuters
·
May 05

Glaukos Highlights Growth Strategy in Interventional Eye Care

TIPRANKS
·
May 04

Glaukos publishes investor presentation on interventional glaucoma, keratoconus treatment pipeline

Reuters
·
May 04

Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX) and Glaukos (GKOS)

TIPRANKS
·
May 04

Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$148

Simply Wall St.
·
May 02

Glaukos (GKOS) Receives a Buy from Mizuho Securities

TIPRANKS
·
May 01